Schrödinger set terms for its planned initial public offering on Monday with plans to offer 10 million shares priced at $14 to $16 each. The drug discovery...
Schrödinger SDGR, +0.00% set terms for its planned initial public offering on Monday with plans to offer 10 million shares priced at $14 to $16 each. The drug discovery software company would raise $160 million at the top of that range. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets are underwriting the deal. The compa...
Read more: Marketwatch
